United Kingdom

People: Eisai Co Ltd (4523.T)

4523.T on Tokyo Stock Exchange

17 Jul 2019
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Kai, Yasunobu 

Mr. Yasunobu Kai has been serving as Executive Officer, Chief Planning Officer of Oncology Business Group and Director of Planning of Oncology Business Group in Eisai Co., Ltd. since June 2018. He joined the Company in April 1986. His previous titles include President of Frontier Drug Development Unit and President of Eisai Value Maximization Systems in the Company.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --